Aqr Capital Management LLC Otonomy, Inc. Transaction History

Aqr Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$3.7 - $4.75 $358,511 - $460,251	-96,895 Reduced 80.84%	22,959 $88,000
Q1 2018 May 15, 2018	SELL	$4.05 - $6.1 $1.51 Million - $2.28 Million	-373,496 Reduced 75.71%	119,854 $503,000
Q4 2017 Feb 14, 2018	SELL	$2.8 - $5.55 $271,387 - $537,928	-96,924 Reduced 16.42%	493,350 $2.74 Million
Q3 2017 Nov 14, 2017	BUY	$3.2 - $20.8 $1.89 Million - $12.3 Million	590,274	590,274 $1.92 Million

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.